BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9

• Press Releases

  Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026

  February 9, 2026

   · 

  3 min read
• Press Releases

  Pendopharm Announces the Approval of Yorvipath® (palopegteriparatide injection) for the Treatment of Chronic Hypoparathyroidism in Adults

  February 9, 2026

   · 

  4 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026

  February 9, 2026

   · 

  2 min read
• Press Releases

  Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026

  February 9, 2026

   · 

  2 min read
• Press Releases

  Hemex Health Receives FDA Breakthrough Device Designation for Gazelle® Hb Variant Test

  February 9, 2026

   · 

  2 min read
• Press Releases

  NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026

  February 9, 2026

   · 

  2 min read
• Press Releases

  R1 Appoints Andy Brailo as Chief Commercial Officer

  February 9, 2026

   · 

  2 min read
• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026

  February 9, 2026

   · 

  4 min read
• Press Releases

  Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

  February 9, 2026

   · 

  5 min read
• Press Releases

  Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026

  February 9, 2026

   · 

  1 min read